FDA News
🇺🇸 FDA Page 3FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Track critical FDA approvals, regulatory updates, and policy shifts impacting drug development and market access in the US. Stay ahead of compliance.
Showing 25–36 of 391 articles
Cardiff Oncology pipeline update: onvansertib trials, FDA meeting, and catalysts
FDA · oncology · 5 min
Dr. Sarah MitchellSyndax pipeline update: Revuforj and Niktimvo catalysts to watch
FDA · 8 min
Dr. Sarah MitchellFDA Approves Lumasiran for PH1: What BD and Investors Should Know
FDA · Acute Hepatic Porphyria · 8 min
Dr. Sarah MitchellNovo Nordisk supply of Wegovy stabilizes as new capacity comes online
FDA · weight loss · 4 min
Dr. Sarah MitchellVabysmo gains EU approval for retinal vein occlusion: what changes next
FDA · retinal vein occlusion · 6 min
Dr. Sarah MitchellGSK’s Blenrep returns to the US market after FDA approves resubmission
FDA · blood cancer · 5 min
Dr. Sarah MitchellModerna mRNA-1083 Phase 3 data show stronger flu and COVID immune response
FDA · COVID-19 · 6 min
Dr. Sarah MitchellFDA approves Vertex’s Journavx as first non-opioid pain drug for acute pain
FDA · moderate-to-severe acute pain · 7 min
Dr. Sarah MitchellFDA approves Vyloy for HER2-negative gastric and GEJ cancer
FDA · HER2-negative gastric cancer · 5 min
Dr. Sarah MitchellNovo Nordisk supply of Wegovy stabilizes as FDA shortage ends
FDA · weight-loss · 5 min
Dr. Sarah MitchellLenacapavir posts 100% HIV prevention in PURPOSE 1
FDA · HIV · 8 min
Dr. Sarah MitchellCobenfy meets endpoint in Bristol Myers Squibb’s Alzheimer’s psychosis trial
FDA · Alzheimer's disease · 6 min
Dr. Sarah MitchellExplore intelligence